Concepedia
Statistics
Publications
12
Citations
843
H-Index
11
Active since
2007
Affiliations
Pfizer (United States)(Current)
Cornell University
Jason Gong is an author at Pfizer (United States) specializing in pharmacotherapy, pharmacology, and medicine.
Publications per year
2007–2016
A double-blind study evaluating the long-term safety of varenicline for smoking cessation
Kathryn Williams, Karen R. Reeves, Clare B. Billing et al. · Current Medical Research and Opinion · 2007 · 189 citations
Pharmacy, Pharmacology, Pharmacotherapy +13
Comparison of fesoterodine and tolterodine extended release for the treatment of overactive bladder: a head‐to‐head placebo‐controlled trial
Sender Herschorn, Steven Swift, Zhonghong Guan et al. · British Journal of Urology · 2009 · 159 citations
Medicine, Pharmacology, Pharmacotherapy +17
Effect of Fesoterodine in Vulnerable Elderly Subjects with Urgency Incontinence: A Double-Blind, Placebo Controlled Trial
Catherine E. DuBeau, Stephen R. Kraus, Tomas L. Griebling et al. · The Journal of Urology · 2013 · 141 citations
Medicine, Pharmacology, Pharmacotherapy +11
Superior efficacy of fesoterodine over tolterodine extended release with rapid onset: a prospective, head‐to‐head, placebo‐controlled trial
Steven A. Kaplan, Tim Schneider, Jenelle E. Foote et al. · British Journal of Urology · 2010 · 99 citations
Randomized, Double-blind, Placebo-controlled Trial of Flexible-dose Fesoterodine in Subjects With Overactive Bladder
Roger R. Dmochowski, Kenneth M. Peters, Jon D. Morrow et al. · Urology · 2009 · 88 citations
1–5 of 12